Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Lingford-Hughes

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Psychopharmacology (Oxford, England)|September 11, 2004
Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for PsychopharmacologyA R Lingford-Hughes, S Welch, D J Nutt, et al.
Journal of Psychopharmacology (Oxford, England)|June 10, 2010
The role of central noradrenergic dysregulation in anxiety disorders: evidence from clinical studiesN J Kalk, D J Nutt, A R Lingford-Hughes
Journal of Psychopharmacology (Oxford, England)|May 26, 2012
BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAPA R Lingford-Hughes, S Welch, L Peters, et al.
Psychopharmacology|May 3, 2005
GABA-benzodiazepine receptor function in alcohol dependence: a combined 11C-flumazenil PET and pharmacodynamic studyA R Lingford-Hughes, S J Wilson, V J Cunningham, et al.
British Medical Bulletin|April 17, 2003
AddictionA R Lingford-Hughes, S J C Davies, S McIver, et al.
Trials|October 18, 2022
FORWARDS-1: an adaptive, single-blind, placebo-controlled ascending dose study of acute baclofen on safety parameters in opioid dependence during methadone-maintenance treatment-a pharmacokinetic-pharmacodynamic studyL M Paterson, D Barker, S Cro, et al.
Synapse (New York, N.Y.)|May 14, 2013
Are prescribed benzodiazepines likely to affect the availability of the 18 kDa translocator protein (TSPO) in PET studies?N J Kalk, D R Owen, R J Tyacke, et al.
Psychopharmacology|February 15, 2011
A pilot study of the effectiveness of D-cycloserine during cue-exposure therapy in abstinent alcohol-dependent subjectsB J Watson, S Wilson, L Griffin, et al.
Journal of Psychopharmacology (Oxford, England)|January 23, 2010
Noradrenergic function in generalized anxiety disorder: impact of treatment with venlafaxine on the physiological and psychological responses to clonidine challengeS D Hood, J K Melichar, L G Taylor, et al.
Alcoholism, Clinical and Experimental Research|September 26, 2000
Levels of gamma-aminobutyric acid-benzodiazepine receptors in abstinent, alcohol-dependent women: preliminary findings from an 123I-iomazenil single photon emission tomography studyA R Lingford-Hughes, P D Acton, S Gacinovic, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Psychopharmacology (Oxford, England)|September 11, 2004
Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for PsychopharmacologyA R Lingford-Hughes, S Welch, D J Nutt, et al.
Journal of Psychopharmacology (Oxford, England)|June 10, 2010
The role of central noradrenergic dysregulation in anxiety disorders: evidence from clinical studiesN J Kalk, D J Nutt, A R Lingford-Hughes
Journal of Psychopharmacology (Oxford, England)|May 26, 2012
BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAPA R Lingford-Hughes, S Welch, L Peters, et al.
Psychopharmacology|May 3, 2005
GABA-benzodiazepine receptor function in alcohol dependence: a combined 11C-flumazenil PET and pharmacodynamic studyA R Lingford-Hughes, S J Wilson, V J Cunningham, et al.
British Medical Bulletin|April 17, 2003
AddictionA R Lingford-Hughes, S J C Davies, S McIver, et al.
Trials|October 18, 2022
FORWARDS-1: an adaptive, single-blind, placebo-controlled ascending dose study of acute baclofen on safety parameters in opioid dependence during methadone-maintenance treatment-a pharmacokinetic-pharmacodynamic studyL M Paterson, D Barker, S Cro, et al.
Synapse (New York, N.Y.)|May 14, 2013
Are prescribed benzodiazepines likely to affect the availability of the 18 kDa translocator protein (TSPO) in PET studies?N J Kalk, D R Owen, R J Tyacke, et al.
Psychopharmacology|February 15, 2011
A pilot study of the effectiveness of D-cycloserine during cue-exposure therapy in abstinent alcohol-dependent subjectsB J Watson, S Wilson, L Griffin, et al.
Journal of Psychopharmacology (Oxford, England)|January 23, 2010
Noradrenergic function in generalized anxiety disorder: impact of treatment with venlafaxine on the physiological and psychological responses to clonidine challengeS D Hood, J K Melichar, L G Taylor, et al.
Alcoholism, Clinical and Experimental Research|September 26, 2000
Levels of gamma-aminobutyric acid-benzodiazepine receptors in abstinent, alcohol-dependent women: preliminary findings from an 123I-iomazenil single photon emission tomography studyA R Lingford-Hughes, P D Acton, S Gacinovic, et al.
Pageof 2